The Wall Street Journal reported Friday that Bausch & Lomb Inc. is nearing a deal to sell itself to Valeant Pharmaceuticals International (VRX) for about $9 billion.
Valeant spiked sharply to the upside midday Friday and finished higher by 9.80 at $84.47, with volume at over an 8-month high. The stock surged past resistance and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.